Clinical Implications of Focal Mineral Deposition in the Globus Pallidus on CT and Quantitative Susceptibility Mapping of MRI

다국어 초록 (Multilingual Abstract)

Objective: To assess focal mineral deposition in the globus pallidus (GP) by CT and quantitative susceptibility mapping (QSM) of MRI scans and evaluate its clinical significance, particularly cerebrovascular degeneration.
Materials and Methods: This study included 105 patients (66.1 ± 13.7 years; 40 male and 65 female) who underwent both CT and MRI with available QSM data between January 2017 and December 2019. The presence of focal mineral deposition in the GP on QSM (GPQSM) and CT (GPCT) was assessed visually using a three-point scale. Cerebrovascular risk factors and small vessel disease (SVD) imaging markers were also assessed. The clinical and radiological findings were compared between the different grades of GPQSM and GPCT. The relationship between GP grades and cerebrovascular risk factors and SVD imaging markers was assessed using univariable and multivariable linear regression analyses.
Results: GPCT and GPQSM were significantly associated (p < 0.001) but were not identical. Higher GPCT and GPQSM grades showed smaller gray matter (p = 0.030 and p = 0.025, respectively) and white matter (p = 0.013 and p = 0.019, respectively) volumes, as well as larger GP volumes (p < 0.001 for both). Among SVD markers, white matter hyperintensity was significantly associated with GPCT (p = 0.006) and brain atrophy was significantly associated with GPQSM (p = 0.032) in at univariable analysis. In multivariable analysis, the normalized volume of the GP was independently positively associated with GPCT (p < 0.001) and GPQSM (p = 0.002), while the normalized volume of the GM was independently negatively associated with GPCT (p = 0.040) and GPQSM (p = 0.035).
Conclusion: Focal mineral deposition in the GP on CT and QSM might be a potential imaging marker of cerebral vascular degeneration. Both were associated with increased GP volume.

참고문헌 (Reference)

1 Sun H, "Validation of quantitative susceptibility mapping with Perls’ iron staining for subcortical gray matter" 105 : 486-492, 2015

2 Ward RJ, "The role of iron in brain ageing and neurodegenerative disorders" 13 : 1045-1060, 2014

3 Ryu K, "Synthesizing T1 weighted MPRAGE image from multi echo GRE images via deep neural network" 64 : 13-20, 2019

4 박미나 ; 문원진, "Structural MR Imaging in the Diagnosis of Alzheimer’s Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives" 대한영상의학회 17 (17): 827-845, 2016

5 Langkammer C, "Quantitative susceptibility mapping (QSM)as a means to measure brain iron? A post mortem validation study" 62 : 1593-1599, 2012

6 Lee WJ, "Progression of cerebral white matter hyperintensities and the associated sonographic index" 284 : 824-833, 2017

7 Goswami R, "Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism" 77 : 200-206, 2012

8 Jang J, "Paradoxical paramagnetic calcifications in the globus pallidus : an ex vivo MR investigation and histological validation study" 34 : e4571-, 2021

9 Osborn AG, "Osborn’s brain e-book" Elsevier 2017

10 Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration" 12 : 822-838, 2013

11 Harder SL, "Mineralization of the deep gray matter with age : a retrospective review with susceptibility-weighted MR imaging" 29 : 176-183, 2008

12 Casanova MF, "Mineralization of the basal ganglia : implications for neuropsychiatry, pathology and neuroimaging" 121 : 59-87, 2003

13 Bilgic B, "MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping" 59 : 2625-2635, 2012

14 Labranche R, "Liver iron quantification with MR imaging : a primer for radiologists" 38 : 392-412, 2018

15 Rouault TA, "Iron metabolism in the CNS : implications for neurodegenerative diseases" 14 : 551-564, 2013

16 Yamada N, "Intracranial calcification on gradient-echo phase image : depiction of diamagnetic susceptibility" 198 : 171-178, 1996

17 Morris CM, "Histochemical distribution of non-haem iron in the human brain" 144 : 235-257, 1992

18 Chew AP, "Hippocampal calcification prevalence at CT : a retrospective review" 265 : 504-510, 2012

19 Walhovd KB, "Effects of age on volumes of cortex, white matter and subcortical structures" 26 : 1261-1270, 2005

20 Raz N, "Differential aging of the human striatum : longitudinal evidence" 24 : 1849-1856, 2003

21 Lee S, "Deep gray matter iron measurement in patients with liver cirrhosis using quantitative susceptibility mapping : relationship with pallidal T1 hyperintensity" 47 : 1342-1349, 2018

22 Chen YC, "Correlation between intracranial arterial calcification and imaging of cerebral small vessel disease" 10 : 426-, 2019

23 Mattson MP, "Calcium and neurodegeneration" 6 : 337-350, 2007

24 Fazekas F, "CT and MRI rating of white matter lesions" 13 (13): 31-36, 2002

25 Oshima S, "Brain mri with quantitative susceptibility mapping : relationship to ct attenuation values" 294 : 600-609, 2020

26 Li Y, "Biometal dyshomeostasis and toxic metal accumulations in the development of Alzheimer’s disease" 10 : 339-, 2017

27 Park KY, "Association between cerebral arterial calcification and brachial-ankle pulse wave velocity in patients with acute ischemic stroke" 61 : 364-370, 2009

28 Poels MM, "Arterial stiffness and cerebral small vessel disease : the Rotterdam Scan Study" 43 : 2637-2642, 2012

29 Zhai FF, "Arterial stiffness and cerebral small vessel disease" 9 : 723-, 2018

30 Aquino D, "Age-related iron deposition in the basal ganglia : quantitative analysis in healthy subjects" 252 : 165-172, 2009

31 Li W, "A method for estimating and removing streaking artifacts in quantitative susceptibility mapping" 108 : 111-122, 2015